News
4d
Green Matters on MSNDanone’s Popular Yocrunch Yogurt Recalled Over Concerns About Plastic ContaminationDanone U.S. has issued a yogurt recall over concerns that some of the yogurt toppers contain plastic. The recall includes nearly 20 flavors.
Grace Therapeutics Announces Submission of New Drug Application to U.S. Food and Drug Administration for GTx-104 ...
New York City food banks aren’t sure how they will survive the administration’s funding cuts, which could also affect the programs they turn to for help.
Marty Makary is the commissioner of the Food and Drug Administration. For more than a century, the U.S. Food and Drug Administration has been a global leader in advancing medical cures, but in ...
The Department of Health and Human Services and the Food and Drug Administration announced on Tuesday a series of measures to phase out eight artificial food dyes.
Yeztugo, a twice-a-year antiviral shot to prevent HIV, was approved by the Food and Drug Administration on Wednesday, marking a major advance in battling AIDS. Yeztugo was approved by the FDA ...
The Food and Drug Administration has approved a new drug that could prevent HIV infections with just two shots every year and possibly eradicate the disease.
A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug Administration to be used to prevent HIV.
On Tuesday, the U.S. Food and Drug Administration announced a new initiative to offer expedited reviews for new medicines, an initiative that will apply to drugs that administration officials ...
The Food and Drug Administration has just approved a preventative HIV drug widely regarded as a breakthrough. On Wednesday afternoon, the FDA approved Gilead Sciences’ lenacapavir as a more ...
The Food and Drug Administration says it will begin offering faster reviews to new medicines that align with Trump administration priorities for Americans' health.
The US Food and Drug Administration announced a new national priority voucher plan that aims to cut drug review times to one to two months for companies it says are backing national interests.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results